Phongphithakchai, A.; Tedasen, A.; Netphakdee, R.; Leelawattana, R.; Srithongkul, T.; Raksasuk, S.; Huang, J.C.; Chatatikun, M.
Dapagliflozin in Chronic Kidney Disease: Insights from Network Pharmacology and Molecular Docking Simulation. Life 2025, 15, 437.
https://doi.org/10.3390/life15030437
AMA Style
Phongphithakchai A, Tedasen A, Netphakdee R, Leelawattana R, Srithongkul T, Raksasuk S, Huang JC, Chatatikun M.
Dapagliflozin in Chronic Kidney Disease: Insights from Network Pharmacology and Molecular Docking Simulation. Life. 2025; 15(3):437.
https://doi.org/10.3390/life15030437
Chicago/Turabian Style
Phongphithakchai, Atthaphong, Aman Tedasen, Ratana Netphakdee, Rattana Leelawattana, Thatsaphan Srithongkul, Sukit Raksasuk, Jason C. Huang, and Moragot Chatatikun.
2025. "Dapagliflozin in Chronic Kidney Disease: Insights from Network Pharmacology and Molecular Docking Simulation" Life 15, no. 3: 437.
https://doi.org/10.3390/life15030437
APA Style
Phongphithakchai, A., Tedasen, A., Netphakdee, R., Leelawattana, R., Srithongkul, T., Raksasuk, S., Huang, J. C., & Chatatikun, M.
(2025). Dapagliflozin in Chronic Kidney Disease: Insights from Network Pharmacology and Molecular Docking Simulation. Life, 15(3), 437.
https://doi.org/10.3390/life15030437
